Cargando…

Maintenance of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients after 1273-mRNA SARS-CoV-2 Vaccination

Continuous evaluation of the coronavirus disease 2019 (COVID-19) vaccine effectiveness in hemodialysis (HD) patients is critical in this immunocompromised patient group with higher mortality rates due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The response towards vac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gonzalez-Perez, Maria, Baranda, Jana, Berges-Buxeda, Marcos J., Conde, Patricia, Pérez-Olmeda, Mayte, Lozano-Ojalvo, Daniel, Cámara, Carmen, del Rosario Llópez-Carratalá, Maria, Gonzalez-Parra, Emilio, Portolés, Pilar, Ortiz, Alberto, Portoles, Jose, Ochando, Jordi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141011/ https://www.ncbi.nlm.nih.gov/pubmed/37111331 http://dx.doi.org/10.3390/ph16040574

Ejemplares similares

Development of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients After 1273-mRNA SARS-CoV-2 Vaccination
por: Gonzalez-Perez, Maria, et al.
Publicado: (2022)

Fracaso renal agudo en pacientes hospitalizados por COVID-19
por: Tarragón, Blanca, et al.
Publicado: (2021)

Acute kidney failure in patients admitted due to COVID-19()
por: Tarragón, Blanca, et al.
Publicado: (2021)

Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naive and COVID-19 recovered individuals
por: Lozano-Ojalvo, Daniel, et al.
Publicado: (2021)

Study of humoral and cellular immunity in vaccinated with mRNA‐1273
por: Gutiérrez‐Bautista, Juan Francisco, et al.
Publicado: (2022)

Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis Patients
por: Broseta, José Jesús, et al.
Publicado: (2021)

Humoral Response after Three Doses of mRNA-1273 or BNT162b2 SARS-CoV-2 Vaccines in Hemodialysis Patients
por: Broseta, José Jesús, et al.
Publicado: (2022)

Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial
por: Borobia, Alberto M, et al.
Publicado: (2021)

Humoral immune response to an mRNA-1273 booster after chAdOx1-nCoV-19-priming among patients undergoing hemodialysis
por: Cheng, Bo-Yu, et al.
Publicado: (2023)

Rapid decline of anti-SARS-CoV-2 antibodies in patients on haemodialysis: the COVID-FRIAT study
por: Alcázar-Arroyo, Roberto, et al.
Publicado: (2021)

Cellular and Humoral Responses in Dialysis Patients after Vaccination with the BNT162b2 or mRNA-1273 Vaccines
por: Mavrovouniotis, Ilias, et al.
Publicado: (2023)

Cellular and humoral immune response after mRNA-1273 SARS-CoV-2 vaccine in liver and heart transplant recipients
por: Herrera, Sabina, et al.
Publicado: (2021)

Mesoporous Bioactive Nanoparticles for Bone Tissue Applications
por: Arcos, Daniel, et al.
Publicado: (2023)

Regular Humoral and Cellular Immune Responses in Individuals with Chronic Myeloid Leukemia Who Received a Full Vaccination Schedule against COVID-19
por: Rodríguez-Mora, Sara, et al.
Publicado: (2023)

Cellular and humoral immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in patients with hematologic malignancies
por: Jiménez, Moraima, et al.
Publicado: (2022)

Marcadores del discurso
por: Portolés, José
Publicado: (2007)

Medio siglo de filología española(1896-1952) : positivismo e idealismo
por: Portolés, José
Publicado: (1986)

Marcadores del discurso /
por: Portolés, José
Publicado: (1998)

Humoral Immunogenicity of the mRNA-1273 Vaccine in the Phase 3 Coronavirus Efficacy (COVE) Trial
por: El Sahly, Hana M, et al.
Publicado: (2022)

Molecular mechanisms involved in HIV latency and implications for HIV treatment and eradication
por: Alcami, Jose, et al.
Publicado: (2010)

PB1944: INDIVIDUALS WITH CHRONIC LYMPHOCYTIC LEUKAEMIA SHOW IMPAIRED HUMORAL BUT NORMAL CELLULAR IMMUNE RESPONSES AFTER RECEIVING A COMPLETE VACCINATION SCHEDULE AGAINST SARS-COV-2
por: Sánchez-Menéndez, Clara, et al.
Publicado: (2023)

Early Cellular and Humoral Responses Developed in Oncohematological Patients after Vaccination with One Dose against COVID-19
por: Rodríguez-Mora, Sara, et al.
Publicado: (2022)

Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study
por: García-Pérez, Javier, et al.
Publicado: (2022)

P1534: MRNA-1273 SARS-COV-2 VACCINE IN RECENTLY TRANSPLANTED ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: CELLULAR AND HUMORAL IMMUNE RESPONSES AND BOOSTER EFFECT
por: Albiol, Nil, et al.
Publicado: (2023)

Role of mTOR inhibitor in the cellular and humoral immune response to a booster dose of SARS-CoV-2 mRNA-1273 vaccine in kidney transplant recipients
por: Pérez-Flores, Isabel, et al.
Publicado: (2023)

La pregunta por el sujeto en la teoría feminista : el debate filosófico actual
por: Oliva Portolés, Asunción
Publicado: (2009)

Humoral response of the mRNA-1273 SARS-CoV-2 vaccine in peritoneal dialysis patients
por: Rodríguez-Espinosa, Diana, et al.
Publicado: (2021)

Strong Cellular Immune Response, but Not Humoral, against SARS-CoV-2 in Oncohematological Patients with Autologous Stem Cell Transplantation after Natural Infection
por: Vigón, Lorena, et al.
Publicado: (2022)

Electron Microscopy Reveals Evidence of Perinuclear Clustering of Mitochondria in Cardiac Biopsy-Proven Allograft Rejection
por: Tarazón, Estefanía, et al.
Publicado: (2022)

mRNA-1273 SARS-CoV-2 vaccine in recently transplanted allogeneic hematopoietic cell transplant recipients: Dynamics of cellular and humoral immune responses and booster effect
por: Albiol, Nil, et al.
Publicado: (2023)

Does Oxidative Stress Induced by Alcohol Consumption Affect Orthodontic Treatment Outcome?
por: Barcia, Jorge M., et al.
Publicado: (2017)

Strong Humoral but Not Cellular Immune Responses against SARS-CoV-2 in Individuals with Oncohematological Disease Who Were Treated with Rituximab before Receiving a Vaccine Booster
por: Torres, Montserrat, et al.
Publicado: (2022)

Clinical Characteristics and Management of Patients with Secondary Hyperparathyroidism Undergoing Hemodialysis: A Feasibility Analysis of Electronic Health Records Using Natural Language Processing
por: Ortiz, Alberto, et al.
Publicado: (2023)

The Functional Interplay between Protein Kinase CK2 and CCA1 Transcriptional Activity Is Essential for Clock Temperature Compensation in Arabidopsis
por: Portolés, Sergi, et al.
Publicado: (2010)

An Immunological Approach to the Biocompatibility of Mesoporous SiO(2)-CaO Nanospheres
por: Montes-Casado, María, et al.
Publicado: (2020)

Carisoprodol Single and Multiple Dose PK-PD. Part II: Pharmacodynamics Evaluation Method for Central Muscle Relaxants. Double-Blind Placebo-Controlled Clinical Trial in Healthy Volunteers
por: Calvo, Aitana, et al.
Publicado: (2022)

Debemos evaluar el daño renal previo en el fracaso renal agudo por COVID-19
por: Tarragón, Blanca, et al.
Publicado: (2022)

We must evaluate the previous kidney damage in the acute kidney failure due to COVID-19
por: Tarragón, Blanca, et al.
Publicado: (2022)

Humoral and cellular immune response over 9 months of mRNA-1273, BNT162b2 and ChAdOx1 vaccination in a University Hospital in Spain
por: Fernández-Ciriza, Leire, et al.
Publicado: (2022)

Comparison of Humoral Antibody Responses and Seroconversion Rates between Two Homologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination in Patients Undergoing Maintenance Hemodialysis
por: Hsiao, Shih-Hsin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m4t27qpa7eeafplu5c9fa6ajqo